These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31661960)

  • 1. AntiBac-Pred: A Web Application for Predicting Antibacterial Activity of Chemical Compounds.
    Pogodin PV; Lagunin AA; Rudik AV; Druzhilovskiy DS; Filimonov DA; Poroikov VV
    J Chem Inf Model; 2019 Nov; 59(11):4513-4518. PubMed ID: 31661960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4(3H)-Quinazolinone derivatives: Promising antibacterial drug leads.
    Gatadi S; Lakshmi TV; Nanduri S
    Eur J Med Chem; 2019 May; 170():157-172. PubMed ID: 30884322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between target-class and the physicochemical properties of antibacterial drugs.
    Mugumbate G; Overington JP
    Bioorg Med Chem; 2015 Aug; 23(16):5218-24. PubMed ID: 25975639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combating multidrug-resistant bacteria: current strategies for the discovery of novel antibacterials.
    O'Connell KM; Hodgkinson JT; Sore HF; Welch M; Salmond GP; Spring DR
    Angew Chem Int Ed Engl; 2013 Oct; 52(41):10706-33. PubMed ID: 24038605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of structure-based design to antibacterial drug discovery.
    Cain R; Narramore S; McPhillie M; Simmons K; Fishwick CW
    Bioorg Chem; 2014 Aug; 55():69-76. PubMed ID: 24962384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolite concentration as a criterion for antibacterial discovery.
    Wang ZY; Zhu Q; Zhang HY
    Curr Comput Aided Drug Des; 2013 Sep; 9(3):412-6. PubMed ID: 24010936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial histidine kinases as novel antibacterial drug targets.
    Bem AE; Velikova N; Pellicer MT; Baarlen Pv; Marina A; Wells JM
    ACS Chem Biol; 2015 Jan; 10(1):213-24. PubMed ID: 25436989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Technology in the Discovery and Development of Novel Antibacterials.
    Chung PY
    Curr Drug Targets; 2018; 19(7):832-840. PubMed ID: 28891454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Antibacterial Compounds and their Drug Targets - Successes and Challenges.
    Kaczor AA; Polski A; Sobótka-Polska K; Pachuta-Stec A; Makarska-Bialokoz M; Pitucha M
    Curr Med Chem; 2017; 24(18):1948-1982. PubMed ID: 27978802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, evaluation, and CoMFA study of fluoroquinophenoxazine derivatives as bacterial topoisomerase IA inhibitors.
    Yu X; Zhang M; Annamalai T; Bansod P; Narula G; Tse-Dinh YC; Sun D
    Eur J Med Chem; 2017 Jan; 125():515-527. PubMed ID: 27689733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ENABLE: an engine for European antibacterial drug discovery and development.
    Olliver M; Griestop L; Hughes D; Belfrage AK; Gising J; Baranczewski P; Vingsbo Lundberg C; Karlén A
    Nat Rev Drug Discov; 2021 Jun; 20(6):407-408. PubMed ID: 33948003
    [No Abstract]   [Full Text] [Related]  

  • 12. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating bacterial molecular genetics with chemical biology for renewed antibacterial drug discovery.
    Parkhill SL; Johnson EO
    Biochem J; 2024 Jul; 481(13):839-864. PubMed ID: 38958473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of SBDD to the discovery of new antibacterial drugs.
    Finn J
    Methods Mol Biol; 2012; 841():291-319. PubMed ID: 22222458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Review of Antibacterial Candidates with New Modes of Action.
    Butler MS; Vollmer W; Goodall ECA; Capon RJ; Henderson IR; Blaskovich MAT
    ACS Infect Dis; 2024 Oct; 10(10):3440-3474. PubMed ID: 39018341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chalcone derivatives and their antibacterial activities: Current development.
    Xu M; Wu P; Shen F; Ji J; Rakesh KP
    Bioorg Chem; 2019 Oct; 91():103133. PubMed ID: 31374524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Origins of the Quinolone Class of Antibacterials: An Expanded "Discovery Story".
    Bisacchi GS
    J Med Chem; 2015 Jun; 58(12):4874-82. PubMed ID: 25738967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Target-specific screening of antivirulence preparations for chronic infection therapy].
    Zigangirova NA; Gintsburg AL
    Zh Mikrobiol Epidemiol Immunobiol; 2011; (4):107-15. PubMed ID: 21913401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bis(N-amidinohydrazones) and N-(amidino)-N'-aryl-bishydrazones: New classes of antibacterial/antifungal agents.
    Shrestha SK; Kril LM; Green KD; Kwiatkowski S; Sviripa VM; Nickell JR; Dwoskin LP; Watt DS; Garneau-Tsodikova S
    Bioorg Med Chem; 2017 Jan; 25(1):58-66. PubMed ID: 27769670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topological Model for the Search of New Antibacterial Drugs. 158 Theoretical Candidates.
    Bueso-Bordils JI; Aleman PA; Zamora LL; Martin-Algarra R; Duart MJ; Antón-Fos GM
    Curr Comput Aided Drug Des; 2015; 11(4):336-45. PubMed ID: 26750567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.